Conroy T. Kevin's Insider Trades & SAST Disclosures
Conroy T. Kevin's most recent trade in Exact Sciences Corp. was a trade of 66,723 Common Stock done at an average price of $22.4 . Disclosure was reported to the exchange on March 7, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Conroy T. Kevin.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.38 per share. | 07 Mar 2025 | 66,723 | 1,203,269 (0%) | 0% | 22.4 | 1,493,261 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 66,723 | 0 | - | - | Stock Options (Right to Buy) | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.06 per share. | 07 Mar 2025 | 48,929 | 1,154,340 (0%) | 0% | 47.1 | 2,302,599 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 22,167 | 66,504 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 22,167 | 1,146,965 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 18,143 | 1,133,326 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 18,143 | 36,286 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.82 per share. | 28 Feb 2025 | 10,419 | 1,136,546 (0%) | 0% | 47.8 | 498,237 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.82 per share. | 28 Feb 2025 | 8,528 | 1,124,798 (0%) | 0% | 47.8 | 407,809 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 111,146 | 111,146 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 13,180 | 13,181 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2025 | 13,180 | 1,121,378 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.28 per share. | 24 Feb 2025 | 6,195 | 1,115,183 (0%) | 0% | 51.3 | 317,680 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 48,044 | 1,129,338 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.48 per share. | 19 Feb 2025 | 21,140 | 1,108,198 (0%) | 0% | 50.5 | 1,067,147 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2025 | 10,374 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2025 | 10,374 | 1,084,565 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.63 per share. | 19 Feb 2025 | 3,271 | 1,081,294 (0%) | 0% | 49.6 | 162,340 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | 31 Dec 2024 | 74,599 | 779,944 (0%) | 0% | 0 | Common Stock | ||
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 51.35 per share. | 13 Nov 2024 | 19,500 | 1,074,191 (0%) | 0% | 51.4 | 1,001,325 | Common Stock |
| Align Technology, Inc. | Kevin T. Conroy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 1,148 | 1,148 | - | - | Restricted Stock Units | |
| Align Technology, Inc. | Kevin T. Conroy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2024 | 660 | 660 (0%) | 0% | 0 | Common Stock | |
| Align Technology, Inc. | Kevin T. Conroy | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2024 | 660 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2024 | 2,489 | 1,156,638 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 60.15 per share. | 30 Apr 2024 | 1,155 | 1,156,191 (0%) | 0% | 60.1 | 69,473 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 30.02 per share. | 30 Apr 2024 | 708 | 1,157,346 (0%) | 0% | 30.0 | 21,254 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 18,143 | 1,307,767 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 18,143 | 54,429 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 59.32 per share. | 29 Feb 2024 | 8,271 | 1,299,496 (0%) | 0% | 59.3 | 490,636 | Common Stock |
| Exact Sciences Corp. | Conroy Kevin T. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 88,671 | 88,671 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | T. Conroy Kevin | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 13,181 | 26,361 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Conroy T. Kevin | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 13,181 | 1,295,887 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Conroy T. Kevin | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 56.89 per share. | 26 Feb 2024 | 6,263 | 1,289,624 (0%) | 0% | 56.9 | 356,302 | Common Stock |
| Exact Sciences Corp. | T. Kevin Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.96 per share. | 23 Feb 2024 | 102,837 | 1,344,266 (0%) | 0% | 14.0 | 1,435,605 | Common Stock |
| Exact Sciences Corp. | T. Kevin Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2024 | 102,837 | 0 | - | - | Stock Option (right to buy) | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.53 per share. | 23 Feb 2024 | 61,560 | 1,282,706 (0%) | 0% | 57.5 | 3,541,547 | Common Stock |
| Exact Sciences Corp. | T. Kevin Conroy | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 23,238 | 1,252,994 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | T. Conroy Kevin | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 59.78 per share. | 21 Feb 2024 | 11,565 | 1,241,429 (0%) | 0% | 59.8 | 691,356 | Common Stock |
| Exact Sciences Corp. | Kevin Conroy T. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 10,374 | 1,234,731 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Feb 2024 | 10,374 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Conroy Kevin T. | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 61.50 per share. | 20 Feb 2024 | 4,975 | 1,229,756 (0%) | 0% | 61.5 | 305,963 | Common Stock |
| Exact Sciences Corp. | Kevin Conroy T. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 31,133 | 1,239,148 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | T. Kevin Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2024 | 31,133 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Conroy T. Kevin | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 61.43 per share. | 14 Feb 2024 | 14,791 | 1,224,357 (0%) | 0% | 61.4 | 908,611 | Common Stock |
| Exact Sciences Corp. | T. Kevin Conroy | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 30.02 per share. | 14 Feb 2024 | 709 | 1,208,015 (0%) | 0% | 30.0 | 21,284 | Common Stock |
| Align Technology, Inc. | Conroy T. Kevin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2023 | 660 | 660 | - | - | Restricted Stock Unit | |
| Adaptive Biotechnologies Corp | Kevin T. Conroy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 23,329 | 23,329 | - | - | Stock Option (right to buy) | |
| Adaptive Biotechnologies Corp | Kevin T. Conroy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 14,775 | 22,968 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 13,180 | 39,541 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 13,180 | 1,208,410 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 61.12 per share. | 27 Feb 2023 | 10,416 | 1,207,306 (0%) | 0% | 61.1 | 636,626 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 9,312 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2023 | 9,312 | 1,217,722 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 72,572 | 72,572 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2023 | 10,374 | 20,747 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2023 | 10,374 | 1,199,994 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 62.72 per share. | 21 Feb 2023 | 4,764 | 1,195,230 (0%) | 0% | 62.7 | 298,798 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2023 | 31,132 | 31,132 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2023 | 31,132 | 1,204,237 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 65.59 per share. | 14 Feb 2023 | 14,617 | 1,189,620 (0%) | 0% | 65.6 | 958,729 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 9,705 | 0 | - | - | Performance Stock Units | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2023 | 9,705 | 1,177,632 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 64.55 per share. | 10 Feb 2023 | 4,527 | 1,173,105 (0%) | 0% | 64.6 | 292,218 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 47.41 per share. | 01 Jul 2022 | 328 | 1,167,934 (0%) | 0% | 47.4 | 15,550 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 40.71 per share. | 01 Jul 2022 | 7 | 1,167,927 (0%) | 0% | 40.7 | 285 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.70 per share. | 17 Mar 2022 | 229,757 | 1,160,741 (0%) | 0% | 5.7 | 1,309,615 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2022 | 229,757 | 0 | - | - | Stock Option (right to buy) | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2022 | 4,612 | 235,388 | - | - | Stock Option (right to buy) | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.68 per share. | 17 Mar 2022 | 4,612 | 1,165,353 (0%) | 0% | 21.7 | 99,988 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2022 | 2,253 | 66,047 | - | - | Stock Option (right to buy) | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.37 per share. | 17 Mar 2022 | 2,253 | 1,167,606 (0%) | 0% | 44.4 | 99,966 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 20,575 | 935,971 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 20,575 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 76.69 per share. | 28 Feb 2022 | 14,299 | 930,984 (0%) | 0% | 76.7 | 1,096,590 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 9,312 | 945,283 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 9,312 | 9,312 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 52,722 | 52,722 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2022 | 10,373 | 31,122 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2022 | 10,373 | 889,067 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 69.05 per share. | 22 Feb 2022 | 5,188 | 883,879 (0%) | 0% | 69.0 | 358,231 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 96,758 | 0 | - | - | Stock Option (right to buy) | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.82 per share. | 14 Feb 2022 | 96,758 | 861,970 (0%) | 0% | 10.8 | 1,046,922 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 94,425 | 0 | - | - | Stock Option (right to buy) | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.07 per share. | 14 Feb 2022 | 94,425 | 765,212 (0%) | 0% | 9.1 | 856,435 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2022 | 31,133 | 62,265 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 78.33 per share. | 14 Feb 2022 | 31,133 | 893,103 (0%) | 0% | 78.3 | 2,438,648 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 79.55 per share. | 14 Feb 2022 | 14,409 | 878,694 (0%) | 0% | 79.6 | 1,146,236 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 6,407 | 670,787 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 93.88 per share. | 01 Nov 2021 | 16,922 | 664,380 (0%) | 0% | 93.9 | 1,588,637 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 93.64 per share. | 01 Oct 2021 | 17,078 | 681,302 (0%) | 0% | 93.6 | 1,599,184 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 104.42 per share. | 01 Sep 2021 | 18,978 | 698,380 (0%) | 0% | 104.4 | 1,981,683 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 107.50 per share. | 02 Aug 2021 | 19,970 | 717,358 (0%) | 0% | 107.5 | 2,146,775 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 123.43 per share. | 01 Jul 2021 | 7,784 | 737,328 (0%) | 0% | 123.4 | 960,779 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 111.00 per share. | 01 Jun 2021 | 12,384 | 745,112 (0%) | 0% | 111 | 1,374,624 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 131.09 per share. | 03 May 2021 | 19,240 | 757,496 (0%) | 0% | 131.1 | 2,522,172 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 64.74 per share. | 03 May 2021 | 328 | 776,736 (0%) | 0% | 64.7 | 21,235 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 132.30 per share. | 01 Apr 2021 | 22,755 | 776,408 (0%) | 0% | 132.3 | 3,010,487 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 20,575 | 808,959 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 20,575 | 20,575 | - | - | Restricted Stock Units | |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 138.42 per share. | 01 Mar 2021 | 9,796 | 799,163 (0%) | 0% | 138.4 | 1,355,962 | Common Stock |
| Exact Sciences Corp. | Kevin T. Conroy | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 136.79 per share. | 26 Feb 2021 | 26,958 | 788,384 (0%) | 0% | 136.8 | 3,687,585 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges